B5. iNOS expression is associated with basal-like breast cancer phenotype and predicts poor survival in ERneg breast cancer
Sharon A. Glynn(Ollscoil na Gaillimhe – University of Galway), Stefan Ambs(University of Maryland, Baltimore), Tiffany M. Howe(National Cancer Institute), David A. Wink(National Cancer Institute), Harris G. Yfantis(University of Maryland, Baltimore), Brenda J. Boersma(Center for Cancer Research), Ming Yi(Science Applications International Corporation (United States)), Lisa A. Ridnour(National Institutes of Health), RJ Stephens(MRC Clinical Trials Unit at UCL), Damali N. Martin(National Institutes of Health)
Cited by 3
Related Papers
Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
|Cancer Research|2008|708
The multifaceted roles of nitric oxide in cancer
|Carcinogenesis|1998|682
“NONOates” (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: Convenient nitric oxide dosage forms
|Methods in enzymology on CD-ROM/Methods in enzymology|1996|674
Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
|Cancer Research|2008|522
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
|Journal of Clinical Investigation|2013|469